Occudo Quantitative Strategies LP Castle Biosciences Inc Transaction History

Occudo Quantitative Strategies LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$19.47 - $28.49 $92,988 - $136,068	-4,776 Reduced 25.06%	14,280 $324,000
Q4 2022 Feb 14, 2023	SELL	$18.08 - $30.0 $60,206 - $99,900	-3,330 Reduced 14.88%	19,056 $448,000
Q3 2022 Nov 14, 2022	SELL	$22.51 - $34.32 $472,642 - $720,617	-20,997 Reduced 48.4%	22,386 $584,000
Q2 2022 Aug 15, 2022	BUY	$16.0 - $45.99 $694,128 - $2 Million	43,383 New	43,383 $952,000

162

25.3M

82.2K

150K

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $559M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.